Stock Price Forecast

March 28, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Evoke Pharma Inc chart...

About the Company

evoke pharma is a biotechnology company located in 505 lomas santa fe dr, solana beach, california, united states.

CEO

David Gonyer

Exchange

NASDAQ

Website

https://evokepharma.com/

$2M

Total Revenue

23

Employees

$2M

Market Capitalization

-0.26

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $EVOK News

Q4 2023 Evoke Pharma Inc Earnings Call

14d ago, source: Yahoo Finance

Matthew D’Onofrio; President and Chief Operations Officer; Evoke Pharma Inc Yale Jen; Analyst; Laidlaw & Company Operator Good afternoon and welcome to the Evoke Pharma fourth-quarter and full ...

Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results

14d ago, source: Business Insider

March 14, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on ...

Evoke Pharma, Inc.: Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D'Onofrio to Chief Executive Officer

7d ago, source:

Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with ...

Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript

13d ago, source: InvestingChannel on MSN

Q4 2023 Earnings Call Transcript March 14, 2024 Evoke Pharma, Inc. misses on earnings expectations. Reported EPS is $-0.59 ...

Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results

14d ago, source:

Balance Sheet Statement of Operations Fiscal year 2023 net product sales from prescriptions totaled approximately $5.2M, a ...

Evoke Pharma Inc EVOK

9d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Evoke Pharma, Inc. (EVOK) Q4 2023 Earnings Call Transcript

14d ago, source: Seeking Alpha

Good afternoon, and welcome to the Evoke Pharma Fourth Quarter and Full-Year 2023 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode. [Operator Instructions ...

Evoke Pharma Inc (EVOK)

3d ago, source: Investing

Investing.com – U.S. stocks were higher after the close on Monday, as gains in the Technology, Utilities and Consumer Services sectors led shares higher. At the ...

Evoke Pharma, Inc.: Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results

15d ago, source: Finanznachrichten

March 14, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...